NCT06845852View on ClinicalTrials.gov

A Phase 1 Mass Balance Study of Varegacestat

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

March 11, 2025

Study Completion Date

March 26, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

varegacestat

Single oral dose of varegacestat

Trial Locations (1)

07094

Frontage Laboratories, Inc., Secaucus

Sponsors

Lead Sponsor

Immunome, Inc.
All Listed Sponsors
lead

Immunome, Inc.

INDUSTRY

NCT06845852 - A Phase 1 Mass Balance Study of Varegacestat | Biotech Hunter | Biotech Hunter